Ojasvi Health Care & Research Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 25 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 M
- Revenue Growth -28.58%
- Profit Growth -28.08%
- Ebitda -50.33%
- Net Worth 6.38%
- Total Assets -0.92%
About Ojasvi Health Care & Research
Ojasvi Health Care & Research Private Limited (OHCRPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2006 and has a history of 19 years. Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M.
Nagavaraprasad Vemuri and Venkata Vemuri serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110AP2006PTC048819
-
Company No.
048819
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jan 2006
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Ojasvi Health Care & Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagavaraprasad Vemuri
|
Director | 19-Jan-2006 | Current |
|
Venkata Vemuri
|
Director | 19-Jan-2006 | Current |
Financial Performance of Ojasvi Health Care & Research.
Ojasvi Health Care & Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.58% decrease. The company also saw a substantial fall in profitability, with a 28.08% decrease in profit. The company's net worth moved up by a moderate rise of 6.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ojasvi Health Care & Research?
Unlock access to Ojasvi Health Care & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2013 | Syndicate Bank | ₹4.50 M | Open |
How Many Employees Work at Ojasvi Health Care & Research?
Unlock and access historical data on people associated with Ojasvi Health Care & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ojasvi Health Care & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ojasvi Health Care & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.